Platelet Resistance to the Antiaggregatory Cyclic Nucleotides in Central Obesity Involves Reduced Phosphorylation of Vasodilator-Stimulated Phosphoprotein
- 1 June 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 53 (6) , 1053-1060
Abstract
Background: Impairment of platelet response to antiaggregatory agents is seen in individuals with central obesity and may play a role in the increased cardiovascular risk associated with obesity. In this study we evaluated whether this impairment involves the antiaggregatory pathways regulated by cAMP and cGMP.Methods: We obtained platelet-rich plasma from 12 obese individuals and 12 controls. We investigated the effects of the cyclic nucleotide analogs 8-pCPT-cAMP (10–500 μmol/L) and 8-pCPT-cGMP (10–500 μmol/L) on ADP-induced platelet aggregation as assessed by decreased light scattering. We assessed the activation of cAMP- and cGMP-dependent protein kinases by measuring phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) at Ser157 and Ser239.Results: The antiaggregatory effect of both cyclic nucleotide analogs was impaired in obese individuals compared to controls, with mean (SE) half-maximal inhibitory concentrations (IC50) (after 20-min incubation) of 123 (33) μmol/L vs 5 (1) μmol/L, respectively, for 8-pCPT-cAMP (P <0.01) and of 172 (43) μmol/L vs 17 (8) μmol/L, respectively, for 8-pCPT-cGMP (P <0.01). The Homeostasis Model Assessment Index of Insulin Resistance was independently correlated with cyclic nucleotide analog IC50. In obese individuals, VASP phosphorylation at Ser157 and Ser239 in response to cyclic nucleotides was significantly lower than in controls.Conclusions: In central obesity the reduced ability of cyclic nucleotides to inhibit platelet aggregation is associated with reduced activation of their specific kinases. Because cyclic nucleotides help regulate platelet antiaggregation, alteration of this ability is consistent with platelet hyperactivity in obesity.Keywords
Funding Information
- Ministero dell’Istruzione, Università e Ricerca
- Regione Piemonte
This publication has 40 references indexed in Scilit:
- IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formationBlood, 2006
- Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin αIIbβ3Blood, 2006
- Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxideBlood, 2004
- The metabolic syndrome: one step forward, two steps backDiabetes & Vascular Disease Research, 2004
- Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesityEuropean Journal of Clinical Investigation, 2004
- A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion FormationJournal of Experimental Medicine, 2002
- Impaired Platelet Sensitivity to the Anti-Aggregating Effects of Adenosine in Obesity and Obese Non-Insulin-Dependent Diabetes mellitus1998
- Dephosphorylation of the focal adhesion protein VASP in vitro and in intact human plateletsFEBS Letters, 1995
- Vasodilator‐stimulated protein phosphorylation in platelets is mediated by cAMP‐ and cGMP‐dependent protein kinasesEuropean Journal of Biochemistry, 1987
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962